Aneurotech SRL
The score of Aneurotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +714 % Total assets +50 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Aneurotech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Oct 2023
Aneurotech's financial analysis
- Solvency21.0%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Aneurotech
Aneurotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0785.263.993
- VAT number
- BE0785263993
- Peppol
- Registered · 0208:0785263993 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Apr 2022
- Registered office
- 3570 Alken
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Aneurotech (SRL) has been based in Alken since 2022, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 701,586 € and equity of 610,913 €; its revenue is not published. Its solvency stands at 21.0%, below the median of its sector (61.7%).
Companies similar to Aneurotech
Companies in the same business, of comparable size and area, outside its group.
- Novobiom Research and experimental development on natural sciences and engineering Liège · balance sheet €3.92m
- Inhatarget Therapeutics Research and experimental development on natural sciences and engineering Charleroi · balance sheet €2.16m
- Stam Agro Research and experimental development on natural sciences and engineering Dendermonde · balance sheet €1.86m
- Puxano Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.43m
- DAU Technology Research and experimental development on natural sciences and engineering Antwerp · balance sheet €3.29m
- Protea Biopharma NV Research and experimental development on natural sciences and engineering Asse · balance sheet €1.30m
- Synlock Engineering activities and related technical consultancy Jemeppe-sur-Sambre · balance sheet €2.67m
- Celyad Oncology Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €4.03m
Frequently asked questions about Aneurotech
What is the revenue of Aneurotech?
Aneurotech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Aneurotech?
In Belgium, the VAT number is the company number prefixed with BE: BE0785263993 for Aneurotech, if the company is VAT-registered. Its company number (CBE) is 0785.263.993.
Where is the registered office of Aneurotech?
According to the CBE register, the registered office of Aneurotech is in 3570 Alken.
What is the equity of Aneurotech?
At the close of the 2025 financial year, the equity of Aneurotech amounts to 610,913 €, a solvency of 21.0% of total assets.
Who manages Aneurotech?
The register lists 4 active mandates at Aneurotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Aneurotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →